State of the Globe: Multimarker Diagnostic Strategies: A Promising Leap Forward in Differentiating Candidemia from Bacteremia
Authors:
Open Access
- 1 October 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Global Infectious Diseases
- Vol. 17 (4) , 167-168
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Evaluation of the Diagnostic Performance of Interleukin-6, C-reactive Protein, and Soluble Triggering Receptor Expressed on Myeloid Cells−1, Individually and Combined, in Differentiating Candidemia from Bacteremia in Intensive Care Unit PatientsJournal of Global Infectious Diseases, 2025
- Evaluating the Diagnostic and Prognostic Value of Interleukin-6 (IL-6) and Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Systemic Inflammatory Response Syndrome (SIRS) and Sepsis in AdultsCureus, 2024
- Significance of biomarkers in stewardship program in pediatric patients infected with Aspergillus speciesItalian Journal of Pediatrics, 2022
- Serum Cytokine Profile in Patients with Candidemia versus BacteremiaPathogens, 2021
- Prognostic Value of Variations in Serum Biomarkers and Prognostic Scores Values Between Admission and Second Day in Intensive Care Unit Septic PatientsCureus, 2021
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016